Cellular methods used to evaluate the immune response in transplantation

Tissue Antigens

Volumn 59, Issue 4, 2002, Pages 241-250

  Reinsmoen, N L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ANTIGEN SPECIFICITY; CELL ASSAY; CLINICAL EXAMINATION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EVALUATION; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MOLECULAR DYNAMICS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TRANSPLANTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT SURVIVAL; HUMAN; TRANSPLANTATION IMMUNOLOGY; HUMANS;

EID: 0036024121     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2002.590401.x     Document Type: Review

References (50)

1. Posttransplant donor antigen-specific hyporeactivity in human transplantation
2. Cellular immunology markers posttransplantation predictive of long-term graft outcome
3. Immune status of recipients following bone marrow-augmented solid organ transplantation
4. Can cellular assays predict chronic rejection?
5. Donor-specific hyporeactivity after liver transplantation
6. Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients
7. Mechanisms of T cell recognition of alloantigen: The role of peptides
8. Clinical significance of in vitro donor-specific hyporesponsiveness in renal allograft recipients as demonstrated by the MLR
9. Loss of direct and maintenance of indirect alloresponses in renal allograft recipients. Implications for the pathogenesis of chronic allograft nephropathy
10. Failure of in vitro T-cell assays to predict clinical outcome after human kidney transplantation
11. Impact of transfusions and acute rejection on posttransplant donor antigen-specific responses in two study populations
12. Pretransplant exposure to donor HLA-DR antigen in random transfusion units and the development of donor antigen-specific hyporeactivity
13. Donor-specific T cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced
14. Clinical significance of selective decline of donor reactive IL-2 producing T lymphocytes after renal transplantation
15. Detection of donor-specific hyporesponsiveness following late failure of human renal allografts
16. Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans
17. Propagation and characterization of lymphocytes from transplant biopsies
18. New strategies for early diagnosis of heart allograft rejection
19. In vitro T cell proliferation from kidney allograft biopsies with unremarkable pathology: New strategies for an old problem
20. Estimation of individual sensitivity to cyclosporin in children awaiting renal transplantation
21. Correlation of in vitro CD4+ T helper cell function with clinical graft status in immunosuppressed kidney transplant recipients
22. Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts
23. Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction
24. Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome
25. Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome
26. Indirect alloresponses are more pronounced in non-rejecting lung than heart allografts
27. Overlap of direct and indirect alloreactive T cell repertoires when MHC polymorphism is limited to the peptide binding groove
28. Human CD25+CD4+ T regulatory cells suppress naïve and memory T cell proliferation and can be expanded in vitro without loss of function
29. Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo
30. Human allograft acceptance is associated with immune regulation
31. low T regulatory cells specific for a donor-derived HLA-B allopeptide mediate CTLA-4 and TaF-(beta)1-dependent inhibition of delayed type hypersensitivity during allograft acceptance
32. Human liver allograft acceptance and the 'Tolerance Assay': In vitro anti-donor T cell assays show hyporeactivity to donor cells but unlike DTH fail to detect linked suppression
33. - T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity
34. Tolerization of dendritic cells by Ts cells: The crucial role of inhibitory receptors ILT3 and ILT4
35. Pretransplant frequency of donor-specific, IFN-γ-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes
36. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte: Reactivity to donor HLA-DR peptides: Potential novel assay for prediction of outcomes for renal transplant recipients
37. Evaluation of the cellular immune response in transplantation
38. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: Evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency
39. Enrichment and detection of live antigen-specific CD4+ and CD8+ T cells based on cytokine secretion
40. High-sensitivity immunofluorescence for detection of the pro- and anti-inflammatory cytokines gamma interferon and interleukin-10 on the surface of cytokine-secreting cells
41. A direct method for the calculation of alloreactive CD4+ T cell precursor frequency
42. T cell effector function and anergy avoidance are quantitatively linked to cell division
43. Immunologic monitoring of T helper cell reactivity
44. HLA-peptide tetrameric complexes
45. A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response
46. Phenotypic analysis of antigen-specific T lymphocytes
47. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules
48. Insights into the specificity and function of (allo)antigen-reactive T cells
49. Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP